Capricorn Fund Managers’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
BC
LSERS
SOADOR
ETC
QCM
PFSRSONJ
RG
YCM
Capricorn Fund Managers's PTCT Position: Q2 2026 in Review
Capricorn Fund Managers opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 63,900 shares worth $5.21M. The stake represents 0.41% of the portfolio and ranks #72 among its holdings.
69 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Capricorn Fund Managers held 63,900 shares of PTC Therapeutics worth $5.21M as of Q2 2026.
- PTC Therapeutics was a new Capricorn Fund Managers position in Q2 2026.
- PTC Therapeutics made up 0.41% of Capricorn Fund Managers's portfolio in Q2 2026, its #72 holding.
- 69 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.